Top Jefferies Blue Chip Value Stocks to Buy Now

Investing

Published: December 18, 2015 10:05 am

Last Updated: January 13, 2020 3:56 pm

With the market volatility ramping up this week, many investors may be looking at their portfolios and wondering if it isn’t time to make some year-end moves. Dividend stocks have suffered this year, and most of the positive upside in the S&P 500 has come from just three momentum stocks.

Each week we cover the new value calls from the analysts at Jefferies, and increasingly some of the calls may look surprising as some solid, big blue chip companies are becoming so cheap on a multiple basis they are ending up in the value arena. This is the best of both worlds for investors, when large cap growth companies become inexpensive enough to have a value call.

Here are three of this week’s value stocks to buy from Jefferies. All are rated Buy.

Abbott Laboratories

This top pharmaceutical stock has very solid growth potential, and was just upgraded to a Buy rating at Jefferies. Abbott Laboratories (NYSE: ABT) is a leading diversified global health care company that develops, manufactures and markets branded generics, medical devices, nutritional products and diagnostic solutions. It recently agreed to acquire the equity in Minnesota-based Tendyne Holdings that it does not already own for $250 million plus future payments tied to regulatory milestones. Wall Street likes the purchase and the way the company is putting its substantial balance sheet to work.